NASDAQ:ITOS

Iteos Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy ITOS

*Your capital is at risk

$10.15

+0 (+0%)

At Close: Nov 17, 2025

Iteos Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -91.05. In total, the insiders bought 1.45M and sold 5.06M ITOS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-91.05
● Buy	1.45M shares
● Sell	5.06M shares
40% Buy Activity Moderate Positive Correlation
Buy Signal Low Confidence May 15, 2025 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -91.05. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Aug 29, 2025 Sell	Common Stock U-Tender	Call Matthew Chief Operating Officer	C-Suite Officer	161 898 Value: $1.63M
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Call Matthew Chief Operating Officer	C-Suite Officer	135 937 Value: $958.4K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Call Matthew Chief Operating Officer	C-Suite Officer	66 170 Value: $195.2K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Call Matthew Chief Operating Officer	C-Suite Officer	146 835 Value: $622.6K
Aug 29, 2025 Sell	Common Stock U-Tender	Detheux Michel Chief Executive Officer	CEO / President	94 027 Value: $944.7K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Detheux Michel Chief Executive Officer	CEO / President	444 815 Value: $3.14M
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Detheux Michel Chief Executive Officer	CEO / President	185 000 Value: $784.4K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Detheux Michel Chief Executive Officer	CEO / President	52 700 Value: $324.6K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Lee David K Director	Director	23 625 Value: $232.5K
Aug 29, 2025 Sell	Common Stock U-Tender	Feltquate David Chief Medical Officer	Officer	47 000 Value: $472.2K
Aug 29, 2025 Sell	Common Stock U-Tender	Gall Matthew Chief Financial Officer	C-Suite Officer	89 429 Value: $898.5K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Gall Matthew Chief Financial Officer	C-Suite Officer	135 937 Value: $958.4K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Gall Matthew Chief Financial Officer	C-Suite Officer	252 135 Value: $1.55M
Aug 29, 2025 Sell	Common Stock U-Tender	Mcgrath Yvonne Chief Scientific Officer	Officer	46 300 Value: $465.2K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Mcgrath Yvonne Chief Scientific Officer	Officer	91 000 Value: $641.6K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Mcgrath Yvonne Chief Scientific Officer	Officer	16 054 Value: $68.1K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Rhoads Ann D Director	Director	27 178 Value: $167.4K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Hallal David Director	Director	25 140 Value: $74.2K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Hallal David Director	Director	146 160 Value: $619.7K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Mcgrath Yvonne Chief Scientific Officer	Officer	16 054 Value: $68.1K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Mcgrath Yvonne Chief Scientific Officer	Officer	91 000 Value: $641.6K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Hallal David Director	Director	146 160 Value: $619.7K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Hallal David Director	Director	25 140 Value: $74.2K
Aug 29, 2025 Sell	Stock Option (Right to Buy) D-Return	Rhoads Ann D Director	Director	27 178 Value: $167.4K
Aug 29, 2025 Sell	Common Stock U-Tender	Mcgrath Yvonne Chief Scientific Officer	Officer	46 300 Value: $465.2K

About Insider Power

Insider Power is a proprietary algorithm developed by Stockinvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks